Hyperparathyroidism is assigned the ICD10 code E21 and the ICD9 code 252.0. It is a condition characterized by excessive production of parathyroid hormone, leading to elevated levels of calcium in the blood. This can result in various symptoms and complications, such as bone pain, kidney stones, and osteoporosis. Proper diagnosis and management are crucial to prevent long-term complications.
Hyperparathyroidism is a medical condition characterized by the overactivity of the parathyroid glands, resulting in excessive production of parathyroid hormone (PTH). The parathyroid glands are responsible for regulating the levels of calcium and phosphate in the body. When these glands become hyperactive, they release too much PTH, leading to elevated levels of calcium in the blood, a condition known as hypercalcemia.
In the International Classification of Diseases, 10th Revision (ICD-10), hyperparathyroidism is classified under the code E21.0. This code specifically refers to primary hyperparathyroidism, which is the most common form of the condition. Primary hyperparathyroidism occurs when a benign tumor develops in one or more of the parathyroid glands, causing them to produce excessive amounts of PTH.
In the previous version of the classification system, ICD-9, hyperparathyroidism was represented by the code 252.0. Similar to ICD-10, the ICD-9 code 252.0 also referred to primary hyperparathyroidism.
It is important to note that there are also other types of hyperparathyroidism, such as secondary and tertiary hyperparathyroidism, which may have different ICD codes. Secondary hyperparathyroidism occurs as a result of another underlying condition, typically chronic kidney disease, while tertiary hyperparathyroidism refers to the autonomous overproduction of PTH by the parathyroid glands, usually after long-standing secondary hyperparathyroidism.
In conclusion, the ICD-10 code for hyperparathyroidism, specifically primary hyperparathyroidism, is E21.0. In the previous ICD-9 version, the code used was 252.0. These codes are used by healthcare professionals for accurate diagnosis, treatment, and billing purposes, ensuring proper classification and management of hyperparathyroidism.